Kimberly Clark Corp vs Teradyne, Inc. — how do they compare? Kimberly Clark Corp trades at $97.59 (market cap $32.51B), while Teradyne, Inc. trades at $402.68 (market cap $62.34B). The key difference: Teradyne, Inc. is the larger of the two by market cap, and Kimberly Clark Corp pays the higher dividend (5.24%). Which is the better fit depends on your goals — on Pluang, investors hold Kimberly Clark Corp for 93 Days and Teradyne, Inc. for 37 Days on average.
| KMB | TER | |
|---|---|---|
Market Cap | $32.51B | $62.34B |
Volume | 6,139,913 | 3,368,404 |
Sector | Consumer Staples | Technology |
52-Week High | $121.44 | $483.84 |
52-Week Low | $93.05 | $132.05 |
Typical Hold Time | 93 Days | 37 Days |
Enterprise Value | $38.07B | $62.08B |
Dividend Yield | 5.24% | 0.13% |
Signals from Pluang's Aura AI — not financial advice
Kimberly-Clark (KMB) trades at $97.74, up 1.31% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong profitability with 11.79% net margins and 129.43% ROE, though Q2 2026 earnings missed expectations. Recent news highlights executive transitions and the pending Kenvue acquisition, while dividend sustainability questions emerge amid cash flow pressures. Analyst consensus remains cautious with 61% hold ratings despite a $117.25 price target suggesting 20% upside.
KMB presents a value opportunity with attractive dividend yield near 5%, but faces integration risks from the Kenvue deal and cash flow challenges. The stock's current discount to analyst targets offers potential upside if execution improves, though investors should monitor dividend coverage and acquisition integration closely given the bearish technical trend and mixed earnings performance.
Teradyne (TER) trades at $398.72, down 3.17% on the day, but maintains a bullish technical outlook with strong support at $388 and resistance at $410. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $2.47 exceeding the $2.09 estimate. Revenue for 2025 reached $3.19 billion, and net income margin stands at 25.77%. Recent developments include the launch of the Magnum E2 memory test system and Iris 100 for microLED devices, targeting AI and high-performance computing demand.
The outlook for TER is positive, driven by AI-driven test equipment demand and consistent earnings outperformance. Risks include reliance on semiconductor cycles and competitive pressure from peers like KLAC. Analysts are bullish with a consensus price target of $461.50, representing a 15.7% upside from the current price. Institutional buying and a lack of sell ratings underscore confidence in growth prospects.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing, which made up 71% of 2021 sales. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
Read more on TER →